The use of cetuximab in the treatment of metastatic colorectal cancer is limited by development of resistance.
Maintenance Treatment with Cetuximab and BAY86-9766 Increases Antitumor Efficacy of Irinotecan plus Cetuximab in Human Colorectal Cancer Xenograft Models / Troiani, Teresa; Napolitano, Stefania; Martini, Giulia; Martinelli, Erika; Cardone, Claudia; Normanno, Nicola; Vitagliano, Donata; Morgillo, Floriana; Fenizia, Francesca; Lambiase, Matilde; Formisano, Luigi; Bianco, Roberto; Ciardiello, Davide; Ciardiello, Fortunato. - In: CLINICAL CANCER RESEARCH. - ISSN 1078-0432. - 21:18(2015), pp. 4153-64-4164. [10.1158/1078-0432.CCR-15-0211]
Maintenance Treatment with Cetuximab and BAY86-9766 Increases Antitumor Efficacy of Irinotecan plus Cetuximab in Human Colorectal Cancer Xenograft Models
TROIANI, TERESA;NAPOLITANO, Stefania;VITAGLIANO, DONATA;FORMISANO, LUIGI;BIANCO, ROBERTO;CIARDIELLO, FORTUNATO
2015
Abstract
The use of cetuximab in the treatment of metastatic colorectal cancer is limited by development of resistance.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
